Literature DB >> 12927658

Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).

Helena J Salomé1, Michael T French, Michael Miller, A Thomas McLellan.   

Abstract

The costs of addiction treatment services are an important determinant of the cost-effectiveness of a program, and therefore, of relevance to addiction treatment providers, insurance companies and, patients. Several methods have been developed to estimate the costs of substance abuse treatment services. One such method is the drug abuse treatment cost analysis program (DATCAP), which collects resource use and cost data from the treatment program perspective and has been used in numerous published economic evaluation studies. However, no single widely-used, standardized instrument is currently available to estimate costs specifically incurred by clients in treatment. In response to that need, this article introduces the Client DATCAP and presents process, survey-specific, and quantitative findings from a Pilot Study to estimate the client costs of attending outpatient and inpatient treatment. The preliminary findings suggest that the self-administered Client DATCAP is a feasible and practical instrument for estimating costs incurred by clients in treatment, with completion time amounting to less than 10 min. Furthermore, client costs had a considerable range across respondents, with time costs consistently accounting for the largest cost component. Findings from the Pilot Study led to the development and release of edition 2 of the outpatient and inpatient modules of the Client DATCAP.

Entities:  

Mesh:

Year:  2003        PMID: 12927658     DOI: 10.1016/s0376-8716(03)00133-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  21 in total

1.  Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Janet Royalty; Amy DeGroff; Djenaba Joseph
Journal:  Eval Program Plann       Date:  2017-02-07

2.  Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.

Authors:  Laura J Dunlap; Gary A Zarkin; Jeremy W Bray; Michael Mills; Daniel R Kivlahan; James R McKay; Patricia Latham; J Scott Tonigan
Journal:  Med Care       Date:  2010-04       Impact factor: 2.983

3.  Estimating the causal effects of cumulative treatment episodes for adolescents using marginal structural models and inverse probability of treatment weighting.

Authors:  Beth Ann Griffin; Rajeev Ramchand; Daniel Almirall; Mary E Slaughter; Lane F Burgette; Daniel F McCaffery
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

4.  Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).

Authors:  Florence K L Tangka; Sujha Subramanian; Sonja Hoover; Janet Royalty; Kristy Joseph; Amy DeGroff; Djenaba Joseph; Sajal Chattopadhyay
Journal:  Eval Program Plann       Date:  2016-12-12

5.  Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Marion Nadel; Robert Smith; Wendy Atkin; Julietta Patnick
Journal:  J Public Health Manag Pract       Date:  2016 Sep-Oct

6.  Developing adaptive interventions for adolescent substance use treatment settings: protocol of an observational, mixed-methods project.

Authors:  Sean Grant; Denis Agniel; Daniel Almirall; Q Burkhart; Sarah B Hunter; Daniel F McCaffrey; Eric R Pedersen; Rajeev Ramchand; Beth Ann Griffin
Journal:  Addict Sci Clin Pract       Date:  2017-12-19

7.  Economic analysis of a multi-site prevention program: assessment of program costs and characterizing site-level variability.

Authors:  Phaedra S Corso; Justin B Ingels; Steven M Kogan; E Michael Foster; Yi-Fu Chen; Gene H Brody
Journal:  Prev Sci       Date:  2013-10

8.  Patient time requirements for anticoagulation therapy with warfarin.

Authors:  Daniel E Jonas; Betsy Bryant Shilliday; W Russell Laundon; Michael Pignone
Journal:  Med Decis Making       Date:  2009-09-22       Impact factor: 2.583

9.  The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP.

Authors:  Kathryn E McCollister; Michael T French; Jeffrey M Pyne; Brenda Booth; Richard Rapp; Carey Carr
Journal:  Drug Alcohol Depend       Date:  2009-07-01       Impact factor: 4.492

Review 10.  Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

Authors:  Christopher M Doran
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.